[go: up one dir, main page]

CL2016001597A1 - Methods of treatment of women with hypoactive sexual desire disorders with combination treatment of bupropion and trazodone - Google Patents

Methods of treatment of women with hypoactive sexual desire disorders with combination treatment of bupropion and trazodone

Info

Publication number
CL2016001597A1
CL2016001597A1 CL2016001597A CL2016001597A CL2016001597A1 CL 2016001597 A1 CL2016001597 A1 CL 2016001597A1 CL 2016001597 A CL2016001597 A CL 2016001597A CL 2016001597 A CL2016001597 A CL 2016001597A CL 2016001597 A1 CL2016001597 A1 CL 2016001597A1
Authority
CL
Chile
Prior art keywords
treatment
trazodone
bupropion
women
methods
Prior art date
Application number
CL2016001597A
Other languages
Spanish (es)
Inventor
E Pyke Robert
Clayton Anita
Taylor Segraves Robert
Derogatis Leonard
Katz Molly
Meston Cindy
G Sitchon Nick
Original Assignee
S1 Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57758862&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2016001597(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by S1 Biopharma Inc filed Critical S1 Biopharma Inc
Publication of CL2016001597A1 publication Critical patent/CL2016001597A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CL2016001597A 2016-06-17 2016-06-20 Methods of treatment of women with hypoactive sexual desire disorders with combination treatment of bupropion and trazodone CL2016001597A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662351904P 2016-06-17 2016-06-17

Publications (1)

Publication Number Publication Date
CL2016001597A1 true CL2016001597A1 (en) 2017-10-06

Family

ID=57758862

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016001597A CL2016001597A1 (en) 2016-06-17 2016-06-20 Methods of treatment of women with hypoactive sexual desire disorders with combination treatment of bupropion and trazodone

Country Status (9)

Country Link
KR (1) KR20170142797A (en)
AR (2) AR105087A1 (en)
AU (1) AU2016204151A1 (en)
CA (1) CA2933921A1 (en)
CL (1) CL2016001597A1 (en)
MX (1) MX2016008272A (en)
PE (1) PE20180023A1 (en)
UY (1) UY36742A (en)
WO (1) WO2017218018A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897864A (en) * 1996-05-23 1999-04-27 Cohen; Alan J. Method for treating sexual dysfunction disorders with compositions containing ginkgo biloba
HUP0202719A3 (en) * 2001-08-21 2006-01-30 Pfizer Prod Inc Pharmaceutical compositions for the treatment of female sexual dysfunctions
WO2005102342A1 (en) * 2004-04-22 2005-11-03 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for the treatment of sexual disorders ii
TW200806300A (en) * 2006-03-24 2008-02-01 Wyeth Corp New therapeutic combinations for the treatment of depression
CN106924259A (en) * 2012-08-06 2017-07-07 S1制药有限公司 Therapeutic scheme

Also Published As

Publication number Publication date
PE20180023A1 (en) 2018-01-09
WO2017218018A1 (en) 2017-12-21
MX2016008272A (en) 2017-12-18
UY36742A (en) 2016-12-30
CA2933921A1 (en) 2017-12-17
AU2016204151A1 (en) 2018-01-18
KR20170142797A (en) 2017-12-28
AR105087A1 (en) 2017-09-06
AR105047A1 (en) 2017-08-30

Similar Documents

Publication Publication Date Title
IL262608A (en) Combined treatment of eye disorders and inflammatory diseases
IL279752A (en) Polycyclic compounds and their use in the treatment of immune disorders
IL273693A (en) Treatment of inflammatory disorders
EP3390634A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR DISEASES
SI3240554T1 (en) Blautia stercosis and wexlerae for use in the treatment of inflammatory and autoimmune diseases
PL3532365T3 (en) Body part and method of manufacturing body parts
IL264949B1 (en) Therapeutic compression device and methods of use
PL3402888T3 (en) MEASURES AND METHODS OF TREATMENT OF HBV
PL3922249T3 (en) DIAGNOSIS AND TREATMENT OF ANXIETY DISORDERS
HUE061761T2 (en) Tetrahydropyranyl-amino-pyrrolopyrimidinone for use in the treatment of BTK-mediated disorders
EP3681479A4 (en) METHOD OF ADMINISTRATION AND TREATMENT
EP3658139A4 (en) METHODS OF TREATMENT OF HEPATIC DISEASES
EP3432888A4 (en) TREATMENT OF CANCER WITH TG02
PL3503890T3 (en) USE OF PRIDOPIDINE IN THE TREATMENT OF DYSTONIA
IL269158A (en) Preparations and methods for the treatment of inflammatory diseases
EP3307280A4 (en) TREATMENT OF SEXUAL DYSFUNCTION
IL264070A (en) Methods and preparations for the treatment of disorders and diseases involving rdh12
EP3503903A4 (en) ASCAROSIDE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES
IL270900A (en) Treatment of skin disorders
HUE059387T2 (en) Treatment of Parkinson's disease
EP3344258A4 (en) TREATMENT OF AUTOIMMUNE DISEASES AND SELF-INFLAMMATORY DISEASES
PL3661510T3 (en) METHODS OF TREATMENT OF BEHAVIORAL CHANGES
IL260987A (en) Treatment and diagnosis of inflammatory disorders
FR3022139B1 (en) NEW COMPOSITIONS FOR THE TREATMENT OF SKIN FLAVORS AND ROSACEA
SMT202100177T1 (en) TREATMENT OF NEUROLOGICAL DISORDERS